Advertisement

Picture [iito] Made Without Love 650x80px

Deals > All

Total search results: 10281 | Ordered by Date (ascending)
1 2 3 ... 101 102 103  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
AES Laboratoire–Mérieux: investment, 201105 acquisition €183m of AES Laboratoire/AES Chemunex by bioMérieux
Agilent–Univ Duisburg-Essen: analytical technology, 201804– collab with new Agilent sponsored Teaching + Research Center for Separation (TRC) at UDE
AiCuris–SEVERAL: investment, 201004 financing round Series B €55m from existing investors led by Santo Holding
Almirall–AB-Biotics: genetic test, 201304 collab existent commercialization of Neurofarmagen developed by AB-Biotics
Bionaturis–BBD Biophenix: investment, 201406 Bionaturis acquires BBD Biophenix S.L., accquisition by Bionaturis S.A.
Biotest–Merck (DE): investment, 201103 acquisition of Biotest microbiology business incl heipha Dr Müller GmbH + Hycon by Merck
Cellerix–Ysios Capital: investment, 200709 Ysios co-leads €27,2million Series B financing of stem cell company Cellerix
Cellestia Biotech–SEVERAL: investment, 201701 seed financing round Series C CHF5.2m from Sotio/PPF Group + private investors
Cellestia Biotech–SEVERAL: investment, <2017 seed financing round Series A CHF0.5m
Cellestia Biotech–SEVERAL: investment, <2017 seed financing round Series B CHF2.3m
Clearstone Central Laboratories–LabCorp: investment, 201106– acquisition €na announced
Eckert & Ziegler–Eckert Wagniskapital: investment, 19?? founding investor Eckert Wagniskapital und Frühphasenfinanzierung GmbH
Endomagnetics–SEVERAL: investment, 201807 financing round Series C $10m (£8m) led by new investor Draper Esprit
Enterome–Gustave Roussy: cancer immunotherapy, 201511– collab microbiome-based drug development
Enterome–SEVERAL: investment, <2012 seed financing round €1.5m Seventure Partners + INRA Transfert
Greenovation–Zukunftsfonds Heilbronn: investment, 201105 existent Greenovation listed as part of portfolio
Immunai–VSC (US): public relations, 202005 service existent by VSC
MedinCell–Gates Foundation: grant, 201911– grant up to $19m over 4 years from Gates Foundation for developm of long-acting contraceptive mdc-WWM
OTHER–Novartis: investment, 201401 acquisition of biologics manufacturing faciltiy in Longmont CO by AveXis
ProQR Therapeutics–SEVERAL: investment, 201711 public offering + concurrent direct offering $20.79m at $3.25/share
Proteome Sciences–SEVERAL: investment, 201402 placing £5m of 18.86m new ordinary shares 28p/share
R-Biopharm–EuroProxima: research antibodies, 201710 acquisition of research antibody line from EuroProxima BV by Progen Biotechnik GmbH
SimplicityBio–TATAA Biocenter: biomarker services, 201610– collab product integration to offer complete biomarker solutions
Sprout Pharmaceuticals–Boehringer: flibanserin, <201303 acquisition of flibanserin from Boehringer Ingelheim
Takeda–Enterome: gastrointestinal drug, 2016– collab drug discovery focussed on microbiome targets
Takeda–Enterome: gastrointestinal drug, 201810– license + collab ww $50m upfront + $640m milestones developm + promotion ww of EB8018
Veterindustria–Triada: public relations, 201504 service existent by Triada Comunicación y Relaciones Públicas
ZIM Plant Technology–Yara: investment, 201311–201401 acquisition by Yara
Univ Alberta–Kratos: mass spectrometer, 197505 supply purchase Kratos Analytical MS-50G by Dept Chemistry MS Facility 1975-05-01
Columbus Pharmaceutical–Boehringer: investment, 1978 acquistion by Boehringer + renamed Roxane Laboratories Inc 1978-01-01
Roche–Hitachi: immunoassay analyser, 1978– collab strategic alliance developm + production of instruments + automated workflows 1978-01-01
Altair–Pharmacia AB: laboratory equipment, 1983– distribution Altair becomes distributor in Japan for Pharmacia (SE) 1983-01-01
API Systems–Mérieux: investment, 1987 acquisition by bioMèrieux 1987-01-01
Univ Alberta–Kratos: mass spectrometer, 198802 supply purchase Kratos Analytical MS-50B by Dept Chemistry MS Facility 1988-02-01
Roche–Sigma-Aldrich: investment, 1989 acquisition of Fluka from Roche + Ciba-Geigy by Sigma-Aldrich 1989-01-01
Commonwealth Holdings–MassMutual: investment, 1990 acquisition $150m of Oppenheimer Management Corp from British & Commonwealth Holdings plc 1990-01-01
Brechbühler–Phenomenex: chromatography consumables, 1991–201708 distribution in Switzerland by Brechbühler TERMINATED 9/17 1991-01-01
Univ Ulm–Thermo Electron: mass spectrometer, 1994 supply Finnigan MAT SSQ-7000 accord to web site of Service Center Mass Spec 1994-01-01
Univ Ulm–Thermo Electron: mass spectrometer, 1994 supply Finnigan MAT TSQ-700 accord to web site of Service Center Mass Spec 1994-01-01
Univ Ulm–Thermo Electron: mass spectrometer, 1994 supply Finnigan MAT TSQ-7000 accord to web site of Service Center Mass Spec 1994-01-01
Techlab–DataApex: chromatography s/w, 1995– distribution of Clarity s/w by Techlab GmbH 1995-01-01
Flamel Technologies–SEVERAL: investment, 1996 IPO €49m at Nasdaq 1996-01-01
Hoechst–Clariant: investment, 1997 acquisition of Hoechst Speciality Chemical Business by Clariant 1997-01-01
Novartis–Yoshitomi Pharmaceutical: fingolimod, 199709– license ww for immunosuppressant FTY720 1997-09-24
Eurofins–SEVERAL: investment, 199710 IPO 1997-10-24
Boehringer Mannheim–Roche: investment, 1998 acquisition by Roche 1998-01-01
Diagnostic Medical Systems–SEVERAL: investment, 1998 IPO at Euronext 1998-01-01
Dima–Meikang Biotech: rapid diagnostics, 1998– distribution of lateral flow quick tests in Europe by Dima GmbH 1998-01-01
Transgene–SEVERAL: investment, 1998 IPO €61.4m at Euronext 1998-01-01
Univ Ulm–Bruker Daltonics: mass spectrometer, 1998 supply Bruker Daltonics REFLEX III MALDI-TOF accord to web site of Service Center Mass Spec 1998-01-01
Stallergenes–SEVERAL: investment, 1998 IPO at Euronext 1998-07-01
Georgia Tech–Waters: mass spectrometer, 1999 supply Micromass Quattro LC installed 1999-01-01
Georgia Tech–Waters: mass spectrometer, 1999 supply Micromass TofSpec2E installed 1999-01-01
Evolva–SEVERAL: investment, 200910 financing round Series B 1st tranche CHF28m 1999-10-22
Evolva–SEVERAL: investment, 200912 financing round Series B 2nd tranche CHF16m incl new + lead investor Entrepreneurs Fund 1999-10-22
Evolva–Ventureast: investment, 200912– commitment to invest CHF5m in Evolva Biotech Pvt Ltd by Ventureast Trustee Co Pvt Ltd 1999-10-22
Nicox–SEVERAL: investment, 199911 IPO €33.2m at Euronext 1999-11-03
CLIB 2021 Cluster–Protagen: industrial biotechnology, 2010 collab Protagen is project partner of CLIB 2021 2000-01-01
OncoTyrol project–Protagen: cancer diagnostics, 2010 collab existent Protagen is project partner of OncoTyrol 2000-01-01
Biocentric–Hain Lifescience: molecular diagnostics, 2001– exclusive distributor of Hain products in France 2001-01-01
Glycotope–Eckert Wagniskapital: investment, 2001 founding investor Eckert Wagniskapital und Frühphasenfinanzierung GmbH 2001-01-01
International Univ Bremen–Bremen (govt): credit, 2003 loan guarantee for €50m given by Federal State of Bremen 2001-01-01
International Univ Bremen–Bremen (govt): grant, 2001 start financing support €230m from Federal State of Bremen 2001-01-01
Per-Form Hungária–Danaher: mass spectrometer, 201909 existent distributor for Sciex technology in Hungary since 2001 2001-01-01
Selexis–SEVERAL: investment, 2001 seed financing CHF100k 2001-01-01
Shimadzu–HCC De Facto: public relations, 200103 service existent for Shimadzu Biotech / Kratos 2001-03-01
Cardion–ROI Verwaltungsgesellschaft: investment, 200107 existent 2001-07-08
Kourion Therapeutics–ROI Verwaltungsgesellschaft: investment, 200107 existent 2001-07-08
NatLifE 2020 project–BRAIN: food biotechnology, 2011– partner + coordinator NatLifE 2020 alliance with 22 partners 2001-11-01
ETG GmbH–Analytik Jena: investment, 2002 acquisition of 20% share by Analytik Jena AG 2002-01-01
Grabner Instruments–Chandler Instruments: investment, 2002 acquisition of Grabner by Chandler 2002-01-01
ANT Teknik–Shimadzu: analytical instruments, 2003– distribution in Turkey of LC + GC + MS et al by ANT Teknik 2003-01-01
BMS–Lonza: biologics contract manufacturing, 2003– supply of commercially marketed biological drug by Lonza 2003-01-01
BMS–Lonza: biologics contract manufacturing, 201410– expansion supply €na incl 2nd commercially marketed biological drug by Lonza 2003-01-01
Chandler Instruments–AMETEK: investment, 2003 acquisition of Chandler Instruments by AMETEK 2003-01-01
Inula–Metrohm: investment, 2003 acquisition 2003-01-01
Minerva Scientific–PerkinElmer: OneSource laboratory management, 2003– supply service 2003-01-01
Bioserv AG–NONE: investment, 200304– bankruptcy filed Local Court Rostock 2003-04-11
Radiometer–Danaher: investment, 200312–200401 acquisition cash tender offer DKK4.4b ($730m) DKK460/share 2003-12-11
Biomendi–GES Genéricos Espanoles: investment, 2004 acquisition 100% 2004-01-01
KaVo Dental–Danaher: investment, 2004 acquisition €350m by Danaher 2004-01-01
Teva–Active Biotech: laquinimod, 2004– license ww marketing + distribution excl Nordic + Baltic regions 2004-01-01
UCB–Amgen: therapeutic antibodies, 2004– collab + license r+d + marketing antibody products targeting protein sclerostin 2004-01-01
ABB–Extrel CMS: investment, 200404 management buyout of ABB mass spectrometer business by Extrel CMS 2004-04-01
Analytical Sciences Group–Intertek: investment, 200405 acquisition 2004-05-01
Sclavo Diagnostics–D-Group: investment, 200406 acquisition 2004-06-01
Univ Alberta–Waters: mass spectrometer, 200408 supply purchase Waters (Micromass) Quattro LC by Dept Chemistry MS Facility 2004-08-01
BASF–Jacobs Univ: SeSaM technology, 200409 license existent filed US + EP patents assigned to BASF AG 2004-09-30
Actelion–Enamine: chemical compound library, 2005– collab supply of screening compound library to Actelion 2005-01-01
Adocia–SEVERAL: investment, 2005 seed financing round €1.8m 2005-01-01
UroGène–Pierre Fabre: investment, 2005 acquisition of UroGène by Groupe Pierre Fabre 2005-01-01
Bruker BioSciences–GeneBio: Phenyx MS software, 200502– collab multi-y ww distribution of Phenyx by Bruker Daltonics with own MS s/w + systems 2005-02-03
Schott–Adcuram: investment, 200503 acquisition of Duran Group by Adcuram 2005-03-01
Univ Alberta–Waters: mass spectrometer, 200503 supply purchase Waters (Micromass) Q-TOF Premier by Dept Chemistry MS Facility 2005-03-01
Agennix–SEVERAL: investment, 200503 private placement $22m 2005-03-30
Syntarga–SEVERAL: investment, 200504 financing round Series A lead investor Aglaia Oncology Fund + co-investor BioPartner Start-up Ventures 2005-04-15
Presearch–United Drug: investment, 200506 acquisition of Presearch Ltd by United Drug plc 2005-06-01
EOS Imaging–LCF Rothschild: investment, 200511 investment by EdRIP 2005-11-01
OncoMethylome–LCF Rothschild: investment, 200511 investment in OncoMethylome by Edmond de Rothschild Investment Partners 2005-11-02
Diaxonhit–SEVERAL: investment, 200511 IPO €7.9m at Alternext 2005-11-17
1 2 3 ... 101 102 103  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top